T Goi
Overview
Explore the profile of T Goi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
292
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yamaguchi A, Saitoh M, Goi T, Deguchi M, Takeuchi K, Maehara M, et al.
Oncol Rep
. 2011 May;
1(4):731-4.
PMID: 21607431
The adhesion of cancer cells to endothelial cells of the target organ is one of the most important steps of hematogenous metastasis. Especially, sialyl Le(X) plays an important role in...
2.
Yamaguchi A, Goi T, Ohtaki N, Seki K, Maehara M, Katayama K, et al.
Oncol Rep
. 2011 May;
4(6):1261-3.
PMID: 21590233
We examined serum SLX for its significance as a tumor marker in 109 colorectal cancer patients. There a close correlation with immunohistochemical expression of SLX and serum SLX level. Serum...
3.
Yamaguchi A, Goi T, Nakagawara G, Ishida T, Miyazaki I
Int J Oncol
. 2011 May;
3(2):279-82.
PMID: 21573360
The effects of prostaglandin E2 and indomethacin on carcinogenesis were studied in male Wistar rats. Of the rats, those treated with MNNG (MNNG group) were given 1 ml of 0.1%...
4.
Goi T, Yamaguchi A, Takeuchi K, Nakagawa G, Yamashiro S, Furukawa K, et al.
Int J Oncol
. 2011 May;
8(4):657-62.
PMID: 21544409
Using a fusion protein encoded by variant exon (v) 8-10 of CD44, a monoclonal antibody (mAb) 44-1V reactive with v9 product was generated. Western immunoblots and reverse transcriptase-polymerase chain reaction/Southern...
5.
Ding K, Yamaguchi A, Goi T, Maehara M, Nakagawara G
Int J Oncol
. 2011 May;
10(4):759-63.
PMID: 21533442
Studies of circulating sialic acid have revealed its relationship with a variety of malignant tumors. It is not vet clear whether sialic acid could be used as a prognostic marker...
6.
Yamaguchi A, Maehara M, Goi T, Katayama K, Hirose K, Nakagawara G
Int J Oncol
. 2011 May;
10(3):581-4.
PMID: 21533416
The expression of bcl-2 protein was studied in invasive breast cancer by immunohistochemistry. Fourty-six (56.8%) bcl-2 protein-positive tumors were found in 81 breast cancers. There was no significant correlation between...
7.
Seki K, Yamaguchi A, Goi T, Nakagawara G, Matsukawa S, Urano T, et al.
Int J Oncol
. 2011 Apr;
11(6):1257-61.
PMID: 21528332
The overexpression of variants of the glycoprotein CD44 is thought to be associated with the tumorigenesis and progression of human cancers. We examined the role of the variant CD44v8-10 in...
8.
Shimizu K, Hirose M, Mikami S, Takamura K, Goi T, Yamaguchi A, et al.
J Hosp Infect
. 2010 Jan;
74(2):129-36.
PMID: 20061057
Perioperative increase in oxidative activity in surgical patients reportedly prevents postoperative surgical site infection (SSI). Several clinical studies have shown that oxidative activity under sevoflurane anaesthesia was higher than that...
9.
Goi T, Senda K, Yamaguchi A
Nihon Geka Gakkai Zasshi
. 2001 Oct;
102(10):783.
PMID: 11681006
No abstract available.
10.
Somatic alterations of the DPC4 and Madr2 genes in colorectal cancers and relationship to metastasis
Ohtaki N, Yamaguchi A, Goi T, Fukaya T, Takeuchi K, Katayama K, et al.
Int J Oncol
. 2001 Feb;
18(2):265-70.
PMID: 11172591
The DPC4 and Madr2 genes are located at 18q21, and the LOH on chromosome 18q21 has been shown to occur frequently in colorectal cancers. To investigate the role of these...